Keiko Mitamura

Summary

Publications

  1. ncbi [Diagnosis and Treatment of influenza--clinical investigation on viral shedding in children with influenza]
    Keiko Mitamura
    Department of Pediatrics, Eiju General Hospital, Japan
    Uirusu 56:109-16. 2006
  2. ncbi Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children
    Norio Sugaya
    Department of Pediatrics, Keiyu Hospital, Yokohama, Kanagawa, Japan
    Clin Infect Dis 47:339-45. 2008
  3. ncbi [Antiviral agents for influenza]
    Keiko Mitamura
    Department of Pediatrics, Eiju General Hospital
    Nippon Rinsho 65:401-6. 2007
  4. ncbi [Pandemic (H1N1) 2009 in children]
    Keiko Mitamura
    Department of Pediatrics, Eiju General Hospital
    Nihon Rinsho 68:1643-9. 2010
  5. ncbi Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children
    Norio Sugaya
    Department of Pediatrics, Keiyu Hospital, Yokohama, Kanagawa, 220 0012, Japan
    Clin Infect Dis 44:197-202. 2007
  6. ncbi [Antiviral agents for influenza]
    Keiko Mitamura
    Department of Pediatrics, Kawasaki Municipal Hospital
    Nippon Rinsho 61:798-803. 2003
  7. ncbi Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
    Shuji Hatakeyama
    Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    JAMA 297:1435-42. 2007
  8. ncbi Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor
    Shuji Hatakeyama
    Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
    J Clin Microbiol 43:4139-46. 2005
  9. ncbi [Evaluation of immunochromatography test for rapid detection of influenza A and B viruses]
    Masahiko Yamazaki
    Zama Children's Clinic
    Kansenshogaku Zasshi 79:29-30. 2005
  10. ncbi [Evaluation of flow-through immunoassay for rapid detection of influenza A and B viruses]
    Masahiko Yamazaki
    Zama Children's Clinic
    Kansenshogaku Zasshi 78:865-71. 2004

Collaborators

  • N Sugaya
  • Kazuhiro Kimura
  • Hiroshi Suzuki
  • F G Hayden
  • Yasuo Suzuki
  • Masayoshi Shinjoh
  • Masahiko Yamazaki
  • Chiharu Kawakami
  • Yoshihiro Kawaoka
  • Shuji Hatakeyama
  • Maki Kiso
  • Hideaki Shimizu
  • Masataka Ichikawa
  • Yuko Sakai-Tagawa
  • Kyoko Shiraishi
  • Osamu Komiyama
  • Mitsunobu Imai
  • Sumi Watanabe
  • Hideo Cho
  • Hideo Goto
  • Darwyn Kobasa
  • Mutsumi Ito
  • Kazuhiko Koike
  • Shiei Kobayashi
  • Yoneyuki Kobayashi
  • Takashi Suzuki
  • Masato Hatta
  • Kyoko Shinya
  • Peter Halfmann
  • M Suresh
  • Yoshinao Takeuchi
  • Heinz Feldmann
  • Takeomi Murata
  • Taichi Usui
  • Steven Theriault
  • Hidekazu Nishimura
  • Ayato Takada
  • Shinji Watanabe
  • Yasuko Maeda

Detail Information

Publications17

  1. ncbi [Diagnosis and Treatment of influenza--clinical investigation on viral shedding in children with influenza]
    Keiko Mitamura
    Department of Pediatrics, Eiju General Hospital, Japan
    Uirusu 56:109-16. 2006
    ..It is very important for influenza control to investigate on viral shedding and resistant viruses...
  2. ncbi Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children
    Norio Sugaya
    Department of Pediatrics, Keiyu Hospital, Yokohama, Kanagawa, Japan
    Clin Infect Dis 47:339-45. 2008
    ..We compared the clinical effectiveness of oseltamivir and zanamivir in children with influenza A (H1N1) virus, influenza A (H3N2) virus, and influenza B virus infections...
  3. ncbi [Antiviral agents for influenza]
    Keiko Mitamura
    Department of Pediatrics, Eiju General Hospital
    Nippon Rinsho 65:401-6. 2007
  4. ncbi [Pandemic (H1N1) 2009 in children]
    Keiko Mitamura
    Department of Pediatrics, Eiju General Hospital
    Nihon Rinsho 68:1643-9. 2010
    ..It is very important to observe clinical course closely and to start neuraminidase inhibitor within 48 hours...
  5. ncbi Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children
    Norio Sugaya
    Department of Pediatrics, Keiyu Hospital, Yokohama, Kanagawa, 220 0012, Japan
    Clin Infect Dis 44:197-202. 2007
    ..This study assesses the effectiveness of oseltamivir against influenza A (H3N2) and influenza B in children on the basis of the duration of febrile illness...
  6. ncbi [Antiviral agents for influenza]
    Keiko Mitamura
    Department of Pediatrics, Kawasaki Municipal Hospital
    Nippon Rinsho 61:798-803. 2003
  7. ncbi Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
    Shuji Hatakeyama
    Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    JAMA 297:1435-42. 2007
    ..Furthermore, transmission of resistant virus, whether influenza A or B, has not been recognized to date...
  8. ncbi Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor
    Shuji Hatakeyama
    Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
    J Clin Microbiol 43:4139-46. 2005
    ..We conclude that the human ST6Gal I-expressing MDCK cell line is useful not only for evaluating their sensitivity to NA inhibitors, but also for isolation of influenza viruses from clinical samples...
  9. ncbi [Evaluation of immunochromatography test for rapid detection of influenza A and B viruses]
    Masahiko Yamazaki
    Zama Children's Clinic
    Kansenshogaku Zasshi 79:29-30. 2005
  10. ncbi [Evaluation of flow-through immunoassay for rapid detection of influenza A and B viruses]
    Masahiko Yamazaki
    Zama Children's Clinic
    Kansenshogaku Zasshi 78:865-71. 2004
    ..These advantages suggest that RapidTesta FLU AB is a useful kit to assist physicians in making a diagnosis of influenza on candidates for antiviral therapy...
  11. ncbi Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus
    Darwyn Kobasa
    Department of Pathobiological Sciences, University of Wisconsin, Madison, Wisconsin 53706, USA
    Nature 431:703-7. 2004
    ....
  12. ncbi [Evaluation of an immunochromatography test using enzyme immunoassay for rapid detection of influenza A and B viruses]
    Keiko Mitamura
    Department of Pediatrics, Kawasaki Municipal Hospital
    Kansenshogaku Zasshi 78:597-603. 2004
    ..6% (81/83) for nasal swabs, and 100% (52/52) for throat swabs. We conclude that the new Espline Influenza A&B-N rapid diagnostic test is easy to use and has a high sensitivity and specificity, especially for influenza A...
  13. ncbi Resistant influenza A viruses in children treated with oseltamivir: descriptive study
    Maki Kiso
    Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
    Lancet 364:759-65. 2004
    ..Furthermore, children can be a source of viral transmission, even after 5 days of treatment with oseltamivir...
  14. ncbi [Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards]
    Masayoshi Shinjoh
    Department of Pediatrics, School of Medicine, Keio University
    Kansenshogaku Zasshi 78:262-9. 2004
    ..No significant adverse effects due to oseltamivir were observed among those who were enrolled in this study...
  15. ncbi [Rapid diagnostic tests for influenza]
    Keiko Mitamura
    Department of Pediatrics, Kawasaki Municipal Hospital
    Nippon Rinsho 61:1914-20. 2003
    ..The rapid tests are also useful for detection of institutional influenza activity. It is important to understand the performance characteristics of the rapid tests...
  16. ncbi High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza
    Kyoko Shiraishi
    Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan
    J Infect Dis 188:57-61. 2003
    ..These results suggest that resistant viruses emerge in a much higher proportion of amantadine-treated patients than has been suggested by previous studies...
  17. ncbi [Effectiveness of oseltamivir treatment against influenza type A and type B infection in children]
    Keiko Mitamura
    Department of Pediatrics, Nippon Kokan Hospital
    Kansenshogaku Zasshi 76:946-52. 2002
    ..No differences in the effectiveness of oseltamivir treatment were observed between young children (< 4 years of age) and school-aged children (> 6 years of age). No obvious side effects were observed...